Report Categories Report Categories

Report Categories

industry Category

All

Total: 5 records, 1 pages

Global Meningococcal Vaccine Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Pharma & Healthcare

new_biaoQian Meningococcal Vaccine

The global Meningococcal Vaccine market size is expected to reach $ 359.8 million by 2030, rising at a market growth of 4.2% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Meningococcal Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Meningococcal Vaccine

According to our (Global Info Research) latest study, the global Meningococcal Vaccine market size was valued at USD 269.6 million in 2023 and is forecast to a readjusted size of USD 359.8 million by 2030 with a CAGR of 4.2% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Quadrivalent Meningococcal Vaccine Supply, Demand and Key Producers, 2024-2030

date 02 Mar 2024

date Pharma & Healthcare

new_biaoQian Quadrivalent Meningococcal Vaccine

The global Quadrivalent Meningococcal Vaccine market size is expected to reach $ 279.3 million by 2030, rising at a market growth of 5.6% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Quadrivalent Meningococcal Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 29 Jan 2024

date Pharma & Healthcare

new_biaoQian Quadrivalent Meningococcal Vaccine

According to our (Global Info Research) latest study, the global Quadrivalent Meningococcal Vaccine market size was valued at USD 190.4 million in 2023 and is forecast to a readjusted size of USD 279.3 million by 2030 with a CAGR of 5.6% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Meningococcal Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

new_biaoQian Meningococcal Vaccine

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.

USD3480.00

Add To Cart

Add To Cart

industry 19 Feb 2024

industry Pharma & Healthcare

new_biaoQian Meningococcal Vaccine

The global Meningococcal Vaccine market size is expected to reach $ 359.8 million by 2030, rising at a market growth of 4.2% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Meningococcal Vaccine

According to our (Global Info Research) latest study, the global Meningococcal Vaccine market size was valued at USD 269.6 million in 2023 and is forecast to a readjusted size of USD 359.8 million by 2030 with a CAGR of 4.2% during review period.

USD3480.00

addToCart

Add To Cart

industry 02 Mar 2024

industry Pharma & Healthcare

new_biaoQian Quadrivalent Meningococcal Vaccine

The global Quadrivalent Meningococcal Vaccine market size is expected to reach $ 279.3 million by 2030, rising at a market growth of 5.6% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 29 Jan 2024

industry Pharma & Healthcare

new_biaoQian Quadrivalent Meningococcal Vaccine

According to our (Global Info Research) latest study, the global Quadrivalent Meningococcal Vaccine market size was valued at USD 190.4 million in 2023 and is forecast to a readjusted size of USD 279.3 million by 2030 with a CAGR of 5.6% during review period.

USD3480.00

addToCart

Add To Cart

industry 18 Mar 2023

industry Pharma & Healthcare

new_biaoQian Meningococcal Vaccine

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.

USD3480.00

addToCart

Add To Cart